Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial

Published:2012-03-13 Issue:4 Volume:157 Page:463-471
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Sive Jonathan I.¹,Buck Georgina²,Fielding Adele³,Lazarus Hillard M.⁴,Litzow Mark R.⁵,Luger Selina⁶,Marks David I.⁷,McMillan Andrew⁸,Moorman Anthony V.⁹,Richards Susan M.²,Rowe Jacob M.¹⁰,Tallman Martin S.¹¹,Goldstone Anthony H.¹

Affiliation:

1. University College London Hospital; London

2. Clinical Trial Service Unit; Oxford

3. Royal Free Hospital; University College London; London; UK

4. University Hospitals Case Medical Center; Cleveland; OH

5. Mayo Clinic; Rochester; MN

6. University of Pennsylvania; Philadelphia; PA; USA

7. University Hospitals Bristol NHS Foundation Trust; Bristol

8. Nottingham City Hospital; Nottingham

9. Northern Institute for Cancer Research; Newcastle University; Newcastle; UK

10. Rambam Medical Centre; Technion; Haifa; Israel

11. Memorial Sloan-Kettering Cancer Center; New York; NY; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2012.09095.x/fullpdf

Reference29 articles.

1. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study;Annino;Blood,2002

2. Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801;DeAngelo;Blood,2007

3. Imatinib significantly enhances long-term outcomes in philadelphia positive acute lymphoblastic leukaemia; final results of the UKALLXII/ECOG2993 Trial;Fielding;Blood,2010

4. Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia;Gardner;Journal of Clinical Oncology,2008

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging CD19CAR T cells early in the treatment of older patients with B-ALL: are we there yet?;Leukemia & Lymphoma;2024-01-05

2. Chimeric Antigen Receptor T-Cell Therapy in Acute Lymphoblastic Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

4. Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis;Clinical Therapeutics;2024-01

5. SOHO State of the Art Updates and Next Questions | Approach to Older Adults With Phildadelphia-Chromosome Negative Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3